JP2007501288A5 - - Google Patents

Download PDF

Info

Publication number
JP2007501288A5
JP2007501288A5 JP2006536536A JP2006536536A JP2007501288A5 JP 2007501288 A5 JP2007501288 A5 JP 2007501288A5 JP 2006536536 A JP2006536536 A JP 2006536536A JP 2006536536 A JP2006536536 A JP 2006536536A JP 2007501288 A5 JP2007501288 A5 JP 2007501288A5
Authority
JP
Japan
Prior art keywords
amino
salt
dione
phenoxy
methoxycarbonylethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2006536536A
Other languages
English (en)
Japanese (ja)
Other versions
JP4833072B2 (ja
JP2007501288A (ja
Filing date
Publication date
Priority claimed from US10/356,113 external-priority patent/US6794401B2/en
Application filed filed Critical
Publication of JP2007501288A publication Critical patent/JP2007501288A/ja
Publication of JP2007501288A5 publication Critical patent/JP2007501288A5/ja
Application granted granted Critical
Publication of JP4833072B2 publication Critical patent/JP4833072B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2006536536A 2003-01-17 2004-01-13 アミノ酸フェノキシエーテル Expired - Fee Related JP4833072B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US44077203P 2003-01-17 2003-01-17
US60/440,772 2003-01-17
US10/356,113 US6794401B2 (en) 2003-01-17 2003-01-31 Amino acid phenoxy ethers
US10/356,113 2003-01-31
PCT/US2004/000790 WO2004066964A2 (en) 2003-01-17 2004-01-13 Amino acid phenoxy ethers

Publications (3)

Publication Number Publication Date
JP2007501288A JP2007501288A (ja) 2007-01-25
JP2007501288A5 true JP2007501288A5 (https=) 2008-12-11
JP4833072B2 JP4833072B2 (ja) 2011-12-07

Family

ID=32716922

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006536536A Expired - Fee Related JP4833072B2 (ja) 2003-01-17 2004-01-13 アミノ酸フェノキシエーテル

Country Status (20)

Country Link
US (2) US6794401B2 (https=)
EP (1) EP1583529B9 (https=)
JP (1) JP4833072B2 (https=)
KR (1) KR101085315B1 (https=)
AT (1) ATE532510T1 (https=)
AU (1) AU2004207449A1 (https=)
BR (1) BRPI0406772B1 (https=)
CA (1) CA2513496C (https=)
CY (1) CY1112673T1 (https=)
DK (1) DK1583529T3 (https=)
EA (1) EA200501078A1 (https=)
ES (1) ES2374724T3 (https=)
MA (1) MA27658A1 (https=)
MX (1) MXPA05007684A (https=)
NO (1) NO330984B1 (https=)
NZ (1) NZ541328A (https=)
PT (1) PT1583529E (https=)
SI (1) SI1583529T1 (https=)
TW (1) TWI325420B (https=)
WO (1) WO2004066964A2 (https=)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7521465B2 (en) * 2003-01-17 2009-04-21 Bexel Pharmaceuticals, Inc. Diphenyl ether derivatives
US7781464B2 (en) * 2003-01-17 2010-08-24 Bexel Pharmaceuticals, Inc. Heterocyclic diphenyl ethers
US7087576B2 (en) * 2003-10-07 2006-08-08 Bexel Pharmaceuticals, Inc. Dipeptide phenyl ethers
US7592486B2 (en) * 2004-09-16 2009-09-22 Board Of Regents Of The University Of Nebraska Anhydrous fluoride salts and reagents and methods for their production
KR20080025662A (ko) * 2005-03-18 2008-03-21 오키드 케미칼즈 앤드 파마수티컬즈 리미티드 신규 티로신 유도체
US20090203744A1 (en) * 2005-07-29 2009-08-13 Pande Y Surendrakumar Satyanarayan Novel pyridine derivatives
WO2008019306A2 (en) * 2006-08-04 2008-02-14 Decode Genetics Ehf Aryl amino acid derivatives as inhibitors of lta4h (leukotriene a4 hydrolase) for treating inflammation
CN101784269A (zh) * 2007-06-26 2010-07-21 莱西肯医药有限公司 治疗由5-羟色胺介导的疾病和病症的方法
CN101815534A (zh) 2007-07-11 2010-08-25 莱西肯医药有限公司 用于治疗肺动脉高压以及相关疾病和病症的方法和组合物
WO2009030968A1 (en) * 2007-09-05 2009-03-12 Orchid Research Laboratories Limited Mao a inhibitors with a diphenyl ether-substructure.
ATE536347T1 (de) 2008-05-20 2011-12-15 Merck Sharp & Dohme Effiziente herstellung heterologer proteine unter verwendung von mannosyltransferaseinhibitoren
US20140187594A1 (en) 2010-07-28 2014-07-03 Orchid Chemicals And Pharmaceuticals Ltd Diphenyl ether compounds for the treatment of liver, lung disorders, diabetic complications and cardiovascular diseases
JP6014816B2 (ja) 2011-05-10 2016-10-26 国立大学法人神戸大学 Ras機能阻害作用を有するチオキソチアゾリジン誘導体

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020049240A1 (en) * 1994-12-19 2002-04-25 Beecham Group P.1.C. Novel compounds
US5166137A (en) 1991-03-27 1992-11-24 Nobipols Forskningsstiftelse Guluronic acid polymers and use of same for inhibition of cytokine production
US5441971A (en) * 1991-04-11 1995-08-15 The Upjohn Company Thiazolidinedione derivatives, production and use thereof
ATE185564T1 (de) * 1992-08-31 1999-10-15 Sankyo Co Oxazolidin-derivate mit antidiabetika und anti- fettleibigkeit-eigenschaften, ihre herstellung und therapeutische verwendung
TW268952B (https=) * 1993-02-26 1996-01-21 Takeda Pharm Industry Co Ltd
AU679572B2 (en) * 1993-09-15 1997-07-03 Daiichi Sankyo Company, Limited Use of thiazolidinediones to prevent or delay onset of NIDDM
US5527546A (en) 1994-08-10 1996-06-18 Bayer Corporation Human interleukin 6 inhibitor
DE4432101A1 (de) * 1994-09-09 1996-03-14 Hoechst Ag Aminosäure-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
JP4173539B2 (ja) 1995-05-11 2008-10-29 ラボラトアール・セローノ・ソシエテ・アノニム Il−6活性阻害剤
CZ293016B6 (cs) * 1995-06-01 2004-01-14 Sankyo Company Limited Benzimidazolové deriváty a farmaceutické prostředky s jejich obsahem
TWI238064B (en) * 1995-06-20 2005-08-21 Takeda Chemical Industries Ltd A pharmaceutical composition for prophylaxis and treatment of diabetes
TW577875B (en) * 1997-01-31 2004-03-01 Shionogi & Co Pyrrolidine derivatives with inhibitory activity for phospholipase A2
JPH11124331A (ja) * 1997-08-21 1999-05-11 Takeda Chem Ind Ltd 抗炎症剤
US6331633B1 (en) 1998-05-08 2001-12-18 Calyx Therapeutics Inc. Heterocyclic analogs of diphenylethylene compounds
US6699896B1 (en) * 1998-05-12 2004-03-02 Wyeth Oxazole-aryl-carboxylic acids useful in the treatment of insulin resistance and hyperglycemia
TR200003595T2 (tr) * 1998-06-05 2001-07-23 Astrazeneca Ab Kimyasal bileşikler
US6664281B1 (en) * 1998-08-27 2003-12-16 Ono Pharmaceutical Co., Ltd. Carboxylic acid derivatives and drugs containing the same as the active ingredient
NZ515086A (en) 1999-04-28 2003-10-31 Aventis Pharma Gmbh Di-aryl acid derivatives as PPAR receptor ligands
TWI284533B (en) * 1999-05-24 2007-08-01 Sankyo Co Pharmaceutical composition for treating hyperglycemia, impaired glucose tolerance, diabetes complications and for improving insulin resistant
EP1109796A1 (en) 1999-07-01 2001-06-27 Geron Corporation Telomerase inhibitors and methods of their use
HUP0202520A3 (en) * 1999-08-23 2004-11-29 Kyorin Seiyaku Kk Substituted benzylthiazolidine-2,4-dione derivatives and pharmaceutical compositions containing them
NZ517993A (en) * 1999-08-31 2004-03-26 Incyte San Diego Inc Benzylidene-thiazolidinediones and analogues and their use in the treatment of diabetes
JP2001199888A (ja) * 2000-01-24 2001-07-24 Fujimoto Brothers:Kk 糖尿病治療剤
JP2001294537A (ja) * 2000-02-10 2001-10-23 Takeda Chem Ind Ltd 併用医薬
ATE310733T1 (de) 2000-04-21 2005-12-15 Pfizer Prod Inc Thyroid-rezeptorliganden
US6680387B2 (en) * 2000-04-24 2004-01-20 Aryx Therapeutics Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis

Similar Documents

Publication Publication Date Title
JP2007501288A5 (https=)
US6498174B1 (en) Substituted oxazoles and thiazoles derivatives as hPPARγ and hPPARα activators
DK2038265T3 (en) Inhibitors of human protein tyrosine phosphatase and methods of use
AU773505B2 (en) Arylthiazolidinedione and aryloxazolidinedione derivatives
CN1186489A (zh) N-苄基二氧代噻唑烷基苯甲酰胺衍生物及其制造方法
HUP0400056A2 (hu) Tiazol- vagy oxazolszármazékok, melyek szív-érrendszeri betegségek gyógyítására alkalmazhatók és a vegyületeket tartalmazó gyógyszerkészítmények
JP2010519181A5 (https=)
JP2005524665A (ja) Ppar活性を調節するチアゾールおよびオキサゾール誘導体
CN1703407A (zh) 脂肪酸酰胺水解酶抑制剂
MXPA02005456A (es) Derivados de oxazoles y tiazoles substituidos como activadores de hppar alfa.
JP3373198B2 (ja) アリールチアゾリジンジオン誘導体
CN1382129A (zh) 取代的苄基噻唑烷-2,4-二酮衍生物
WO2012074980A2 (en) Methods of treating or preventing autoimmune disorders and liver disorders using indane acetic acid derivatives
CN100439345C (zh) 作为用于治疗 2型糠尿病和动脉硬化症的ppar调节剂的 3 - ( 2 -苯基 -噁唑-4-基甲氧基)环己基甲氧基乙酸衍生物和相关化合物
KR100718906B1 (ko) 디히드로나프탈렌 유도체 화합물 및 이 화합물을 유효성분으로 하는 약제
AU2001258841B2 (en) Heterocyclic compounds
JP2008530242A5 (https=)
JP2013507397A5 (https=)
TW200418792A (en) Amino acid phenoxy ethers
WO2010082212A2 (en) N-biphenylacyl thiazolidine-2,4-dione derivatives, their synthesis and uses
Ortiz et al. Synthetic thiazolidinediones: potential antidiabetic compounds
RU2006102866A (ru) Тиазолзамещенные индолилпроизводные и их применение в качестве модуляторов ppar
EP2226321A3 (en) Process for producing thiazolidinediones and intermediates thereof
RU2005141516A (ru) Производные анилина
JP3884736B2 (ja) ハロゲノベンジルアミノプロピオン酸誘導体